King Pharmaceuticals KG AmTrust Legacy Segment — Net premiums written
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PremiumsWrittenNet.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's amtrust legacy segment — net premiums written.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's amtrust legacy segment — net premiums written?
- King Pharmaceuticals (KG) reported amtrust legacy segment — net premiums written of $1.88M in Q1 2026.
- What does amtrust legacy segment — net premiums written mean?
- This metric represents the total premiums on insurance policies issued by the AmTrust Legacy segment during a specific period, net of reinsurance ceded. It serves as a primary indicator of the segment's top-line underwriting activity and market reach within its specialized legacy insurance portfolios. Tracking this figure helps investors assess the volume of business being underwritten before accounting for the timing of revenue recognition.